Paradigm
Integrated clinical trial platform that simplifies access for patients and providers.
What they do
Paradigm offers an end-to-end clinical trial platform designed to integrate trials into routine clinical care. The software connects healthcare providers and pharmaceutical sponsors, reducing the administrative burden on sites and making clinical research accessible to a more diverse patient population.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Trial administration
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- New York, United States
- Region
- North America
- Founded
- 2022
- Total funding
- $203M raised
Notable investors: Arch Venture Partners, General Catalyst, F-Prime Capital.